Dual-chamber implantable cardioverter-defibrillators use automated algorithms to discriminate supraventricular tachycardia from dangerous ventricular arrhythmias. However, complex electrophysiologic rhythms can deceive standard dual-chamber devices. When tachycardias feature simultaneous atrial and ventricular depolarization, device sensors often fail to record the proper event sequence. Consequently, the device may mislabel benign rhythms as ventricular tachycardia and deliver inappropriate therapies. Clinicians can resolve these puzzling device episodes by using a systematic electrogram approach. By carefully interrogating stored intracardiac tracings, electrophysiologists can expose underlying conduction dynamics. Furthermore, this method prevents harmful therapies and guides targeted catheter ablation.

The Challenge of Atrial Blanking in Device Programming

Modern dual-chamber defibrillators typically categorize tachycardias by analyzing the ratio of sensed atrial to ventricular events. In classic ventricular tachycardia, ventricular signals outnumber atrial depolarizations. However, supraventricular tachycardias with very short ventriculoatrial intervals generate a confusing "V-on-A" activation pattern. In typical slow-fast atrioventricular nodal re-entrant tachycardia, retrograde atrial activation occurs almost simultaneously with ventricular activation. Consequently, the retrograde atrial depolarization often falls directly inside the post-ventricular atrial blanking period.

Manufacturers incorporate this blanking window to prevent inappropriate sensing of ventricular far-field potentials. Unfortunately, the refractory interval blinds the atrial sense channel to genuine atrial depolarizations. Therefore, the device undercounts atrial events and registers an apparent excess of ventricular activity. In a recent clinical case, a 75-year-old man with cardiomyopathy experienced 74 tachycardia episodes. The device classified these runs as nonsustained ventricular tachycardia and initiated antitachycardia pacing. Because atrial blanking masked retrograde conduction, the automated algorithm failed completely.

Decoding Initiation: Question One of the Electrogram Approach

To prevent inappropriate device therapies, clinicians must review stored electrograms rather than trusting automated logs. The first diagnostic question examines how the tachycardia initiates. True ventricular tachycardia almost universally starts with an abrupt premature ventricular complex without preceding atrial conduction. In contrast, supraventricular tachycardias depend on atrial triggers or conduction delays across the atrioventricular junction. Specifically, typical atrioventricular nodal re-entrant tachycardia initiates after a premature atrial contraction that conducts down the slow pathway with PR prolongation.

In this patient, careful inspection of stored onset electrograms revealed an initiating atrial depolarization. Furthermore, this impulse conducted antegradely across the atrioventricular node with marked delay before initiating tachycardia. If ventricular tachycardia were present, the onset tracing would display an early ventricular electrogram without antecedent conduction delay. Thus, evaluating the initiation beat provides crucial mechanistic evidence that contradicts automated classifications.

Evaluating Pacing Response and Wobble Dynamics

The second and third diagnostic questions assess how the rhythm behaves during perturbations and spontaneous rate fluctuations. Question two investigates the tachycardia response to ventricular overdrive pacing, including delivered antitachycardia pacing bursts. When pacing entrains ventricular tachycardia, stimulation originates directly within ventricular myocardium. Conversely, when pacing attempts to capture a supraventricular circuit, retrograde conduction must reset the re-entrant loop. In this patient, antitachycardia pacing advanced the atrial electrograms without terminating the arrhythmia, confirming successful reset of an upper chamber circuit.

Question three analyzes the direction of cycle-length wobble during spontaneous rate changes. Rhythms rarely display perfectly static cycle lengths. In ventricular tachycardia, rate wobble originates in the ventricles, meaning ventricular interval shifts precede atrial changes. Conversely, in atrioventricular nodal re-entrant tachycardia, subtle nodal conduction shifts cause atrial fluctuations to dictate subsequent ventricular timing. In this case, atrial intervals clearly drove the wobble. Consequently, cycle-length dynamics excluded a ventricular origin.

Analyzing Termination to Confirm the Arrhythmia Circuit

The fourth diagnostic question examines the precise mechanism of arrhythmia termination. Whether a tachycardia terminates spontaneously or following intervention, the terminal electrogram provides vital diagnostic clarity. Ventricular tachycardia typically terminates with a ventricular electrogram that fails to conduct retrogradely. In contrast, supraventricular tachycardias involving the atrioventricular node frequently terminate with an atrial activation that blocks antegradely in the nodal slow pathway.

Stored electrograms in this case demonstrated that tachycardia consistently ended with a retrograde atrial event that failed to excite the ventricle. This observation proved that conduction block occurred within the atrioventricular node. Therefore, the terminating sequence definitively ruled out ventricular tachycardia, which cannot terminate in the atrium while leaving the atrioventricular node quiescent. By synthesizing the answers to all four questions, clinicians established a confident diagnosis of typical slow-fast atrioventricular nodal re-entrant tachycardia.

Clinical Outcomes and Definitive Catheter Ablation

Inappropriate defibrillator therapies carry substantial clinical hazards for cardiac patients. Recurrent antitachycardia pacing and inappropriate high-voltage shocks cause intense psychological trauma, exacerbate heart failure, and increase all-cause mortality. Moreover, unnecessary pacing bursts can paradoxically trigger malignant ventricular fibrillation. When automated discrimination fails due to atrial blanking, clinicians must identify the underlying supraventricular mechanism to prevent recurring device interventions.

Following the systematic electrogram review, clinicians referred the patient for an invasive electrophysiology study. The study confirmed typical atrioventricular nodal re-entrant tachycardia with an ultra-short ventriculoatrial interval of less than 40 milliseconds. The electrophysiologist successfully performed radiofrequency catheter modification of the slow pathway without complications. Afterward, programmed stimulation demonstrated complete non-inducibility of tachycardia. During prolonged outpatient follow-up, the patient experienced no further palpitations or inappropriate device activations. Thus, meticulous electrogram analysis guided definitive curative therapy.

Frequently Asked Questions

What causes atrial blanking to misclassify supraventricular tachycardia as ventricular tachycardia?

Dual-chamber devices rely on programmed blanking periods after ventricular sensing to avoid detecting ventricular far-field signals on the atrial channel. When supraventricular tachycardias exhibit very short ventriculoatrial intervals, retrograde atrial signals fall directly into this post-ventricular atrial blanking window. Consequently, the device undercounts atrial depolarizations while counting every ventricular event. The automated algorithm senses a false excess of ventricular depolarizations, which prompts it to classify the rhythm erroneously as ventricular tachycardia.

What are the four questions used to evaluate stored electrograms?

The structured four-question approach evaluates distinct electrophysiologic transitions on stored tracings. First, clinicians identify how the tachycardia initiates, checking for atrial or ventricular premature beats. Second, they examine the rhythm's response to ventricular pacing, observing entrainment characteristics. Third, clinicians evaluate cycle-length wobble to determine whether atrial or ventricular timing drives spontaneous rate variations. Finally, they analyze how the tachycardia terminates. Together, these four targeted questions expose the arrhythmia mechanism and separate supraventricular from ventricular events.

How does catheter ablation resolve inappropriate implantable defibrillator therapies?

Catheter ablation directly targets the arrhythmogenic substrate responsible for triggering recurrent device interventions. In patients with atrioventricular nodal re-entrant tachycardia, radiofrequency ablation safely modifies the slow pathway, eliminating the re-entrant circuit entirely. By curing the underlying supraventricular arrhythmia, ablation prevents rapid heart rates that confuse device discrimination algorithms. Consequently, patients avoid unnecessary antitachycardia pacing bursts, painful shocks, and related hospitalizations. This definitive intervention restores normal conduction dynamics, protects device battery life, and substantially improves overall quality of life.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.

References

1. Alnazeer M et al. V-on-A Tachycardia Misclassified as Ventricular Tachycardia by Atrial Blanking: A 4-Question Electrogram Approach. JACC Case Rep. 2026 Sep 06. doi: undefined. PMID: 42704323.
2. Wilkoff BL, Fauchier L, Stiles MK, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2016;13(2):e50-e86.
3. Sternick EB, Wellens HJ. Diagnostic criteria of broad QRS complex tachycardia: decades of evolution. Europace. 2011;13(4):465-472.
4. Ellenbogen KA, Wilkoff BL, Kay GN, Lau CP. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. 5th ed. Elsevier; 2017.